Idibell

A bone scan tracks the process of osseointegration in dental implants

Leave a Comment / Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention Program, Odontological and maxillofacial pathology and therapeutics , Traslacional Medicine / By

The study developed by researchers of the research group of the Odontological and Maxillofacial Pathology and Therapeutics at the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) concludes that bone scintigraphy may be a suitable technique for monitoring the procedure in bone integration implants. The paper has been published in the June […]

A bone scan tracks the process of osseointegration in dental implants Read More »

Josep Manuel Menchón, appointed new Scientific Director of IDIBELL

Leave a Comment / Cancer Epigenetics, Neuroscience Area, Neuroscience Program, Psychiatry and Mental Health  / By

The Board of Trustees of IDIBELL has appointed Josep Manuel Menchón as new Scientific Director of the centre. Dr. Menchón is a renowned physician and researcher in the field of psychiatry and mental health. The new Scientific Director will replace, from October 1st, Gabriel Capellá, who has held this position since 2009. The Board has

Josep Manuel Menchón, appointed new Scientific Director of IDIBELL Read More »

Alfons Nonell: ”the application of computer tools saves time and money to researcher”

Leave a Comment / Innovation / By

The application of computing in science has increased dramatically in recent years to the point that it is becoming common to use computational tools to understand, plan and complete the experimental results obtained in the laboratory. Alfons Nonell is CEO of Mind the Byte, a company located on the campus of Bellvitge, in the bioincubator

Alfons Nonell: ”the application of computer tools saves time and money to researcher” Read More »

Poisoning from industrial compounds can cause similar effects to ALS

Leave a Comment / Cellular and molecular basis of sensory disorders, Neuroscience Area, Neuroscience Program / By

Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) at the University of Barcelona (UB) have coordinated a research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease. The study, led by Jordi Llorens, has been recently published in Neuropathology and Applied Neurobiology

Poisoning from industrial compounds can cause similar effects to ALS Read More »

Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience

Innovation / By

Grifols the world’s third largest plasma product manufacturer and a pioneer in the research and development of therapeutic alternatives designed to contribute to both scientific and social development, has acquired 40% of the equity of Catalan biotechnology firm VCN Biosciences, dedicated to the research and development of new therapeutic approaches for tumors for which there

Grifols acquires 40% of the capital of biotechnology firm VCN Bioscience Read More »

Barbara Marte, Nature editor: ”Now we are publishing more documents than ever”

Leave a Comment / Sin categorizar / By

Nature, first published on 1869, is the leading weekly, international scientific journal. Most scientific journals are now highly specialized, and Nature is among the few journals that still publish original research articles across a wide range of scientific fields. Nature is a private owned publication. The Nature Published Group (NPG) includes Nature, Nature Research Journals,

Barbara Marte, Nature editor: ”Now we are publishing more documents than ever” Read More »

The activation of VRK1, new step in the response to DNA damage

Leave a Comment / Sin categorizar / By

Relationship between cancer and VRK1, a chromatin kinase implicated in DNA damage responses, related to neurodegenerative diseases. The group of Pedro A. Lazo, researcher at the Institute of Molecular and Cellular Biology of Cancer, from CSIC and the University of Salamanca, is investigating the role of VRK1 kinase in response to cell damage and how

The activation of VRK1, new step in the response to DNA damage Read More »

Manel Esteller opens the First International Conference on Biology of Catalonia

Leave a Comment / Sin categorizar / By

The First International Conference of Biology of Catalonia joins more than eight hundred scientists from around the world The First International Conference on Biology of Catalonia, entitled “Global advanced questions on Biology,” will be opened with the conference “Epigenètica: de la biologia a la malaltia” by Manel Esteller, researcher at the Bellvitge Biomedical Research Institute

Manel Esteller opens the First International Conference on Biology of Catalonia Read More »

Alliance to develop new personalized treatments against lung cancer

Leave a Comment / Cancer Epigenetics / By

The Bellvitge Biomedical Research Institute (IDIBELL) has participated in the “Cancer of lungs: the molecular knowledge to treatment” international meeting co-organized with the Centre for Applied Medical Research (CIMA), from the University of Navarra. This event, framed within the Curelung project funded by the European Commission, brought international experts who presented the latest scientific and

Alliance to develop new personalized treatments against lung cancer Read More »

Jaume Reventós: “We need to learn how dogs find cancer by the smell”

Leave a Comment / Sin categorizar / By

Jaume Reventós, PhD, from VHIR, gave a lecture at the hall of the Hospital Duran i Reynals (ICO) on last 29th June. He questioned the current diagnostic tests for prostate cancer and he talked about the kit he is developing to prevent up to 34% of current biopsies. He also spoke of the study about

Jaume Reventós: “We need to learn how dogs find cancer by the smell” Read More »

Scroll to Top